Mark J. Rosenblum
CIK: 0001329154
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DCOY
Decoy Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
About Rosenblum Mark J
Rosenblum Mark J (SEC CIK 0001329154) files insider reports with the SEC as Chief Financial Officer of Decoy Therapeutics Inc. (DCOY).
Signal8 holds 2 ownership filings by Rosenblum Mark J, all Form 4s, filed between Nov 20, 2025 and Sep 2, 2026. Those filings report 2 transactions, from Nov 20, 2025 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rosenblum Mark J's filings is in HOUSTON, TX.
Recent filings by Rosenblum Mark J
Other insiders filing for Decoy Therapeutics Inc. (DCOY)
- Lieber Jonathan I, Director
- PIERCE FREDERICK II, Chief Executive Officer
- Marschel Peter Klaus, Chief Business Officer
- Hibner Barbara Louise, Chief Scientific Officer
- HANISH ARNOLD C, Director
- Lammers Paul, Director